
Loading, please wait...

Loading, please wait...

Physicians recently identified a rare case of neonatal mesenchymal hamartoma in the right ventricle of a newborn infant. This condition is particularly unusual because most documented cases typically occur in the left ventricle. Consequently, the mass led to significant clinical complications, including pericardial effusion and cardiac tamponade shortly after birth. Because early diagnosis is vital, this case highlights the critical role of advanced imaging in neonatal cardiology.
Clinicians initially suspected the cardiac mass during prenatal screenings. However, the definitive diagnosis required comprehensive postnatal investigation using advanced diagnostic tools. Specifically, cardiac MRI provided detailed visualization of the right ventricular mass and its relationship with surrounding cardiac structures. Furthermore, histopathological analysis confirmed the tumor as a mesenchymal hamartoma. Because these tumors can cause life-threatening hemodynamic instability, prompt recognition and characterization are essential for improving neonatal survival rates.
While many cardiac tumors in neonates are histologically benign, their location often dictates the severity of clinical symptoms. Specifically, a right ventricular mass can obstruct blood flow or lead to rapid fluid accumulation in the pericardial sac. Therefore, a multidisciplinary team including neonatologists and cardiothoracic surgeons must manage such cases with urgency. Treatment strategies typically focus on relieving intrapericardial pressure and preventing further cardiac compromise. Additionally, long-term monitoring ensures that the patient remains stable following initial stabilization or surgical intervention.
Symptoms often include respiratory distress, cyanosis, and poor feeding. In severe cases, signs of cardiac tamponade such as hypotension and muffled heart sounds may appear.
Physicians primarily use echocardiography and cardiac MRI to assess tumor morphology and location. However, histopathology remains the gold standard for distinguishing mesenchymal hamartomas from rhabdomyomas or fibromas.
Surgery is usually necessary if the mass causes hemodynamic obstruction, life-threatening arrhythmias, or persistent pericardial effusion. Asymptomatic cases may occasionally be managed with close observation.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Explore a rare case of neonatal right ventricular mesenchymal hamartoma causing cardiac tamponade, highlighting the roles of MRI and histopathology in diagn...
6 months ago

A new case study illuminates how functional connectivity changes drive recovery from pure alexia following posterior cerebral artery infarction. Functional reorganization supports reading recovery despite permanent structural tract disconnection, highlighting key implications for stroke rehabilitation.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today